BFM
WST icon

Boothbay Fund Management’s West Pharmaceutical WST Stock Holding History

Boothbay Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
4,988
+3,133
+169% +$958K 0.02% 775
2026
Q1 		$465K Sell
1,855
-558
-23% -$139K 0.01% 1393
2025
Q4 		$664K Buy
+2,413
New +$660K 0.01% 988
2024
Q4 		– Sell
-3,488
Closed -$1.05M – 1947
2024
Q3 		$1.05M Buy
3,488
+2,166
+164% +$663K 0.02% 736
2024
Q2 		$435K Buy
+1,322
New +$467K 0.01% 1034
2024
Q1 		– Sell
-1,970
Closed -$694K – 1964
2023
Q4 		$694K Buy
1,970
+362
+23% +$128K 0.02% 857
2023
Q3 		$603K Buy
+1,608
New +$622K 0.01% 959
2023
Q2 		– Sell
-4,984
Closed -$1.73M – 2358
2023
Q1 		$1.73M Buy
+4,984
New +$1.46M 0.04% 738
2022
Q4 		– Sell
-3,143
Closed -$773K – 2494
2022
Q3 		$773K Buy
+3,143
New +$957K 0.02% 1009
2021
Q3 		– Sell
-1,288
Closed -$463K – 2220
2021
Q2 		$463K Buy
+1,288
New +$426K 0.01% 1045

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boothbay Fund Management's WST Position: Q2 2026 in Review

Boothbay Fund Management increased its West Pharmaceutical (WST) stake by 169% in Q2 2026, buying an estimated $958K and bringing the position to 4,988 shares worth $1.79M. The position accounts for 0.02% of the portfolio, ranked #775.

Boothbay Fund Management first reported a position in WST in Q2 2021 and has held it in 10 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Boothbay Fund Management held 4,988 shares of West Pharmaceutical worth $1.79M as of Q2 2026.
  • Boothbay Fund Management bought 3,133 West Pharmaceutical shares in Q2 2026, an estimated $958K.
  • West Pharmaceutical made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #775 holding.
  • Boothbay Fund Management first reported a position in West Pharmaceutical in Q2 2021 and has held it in 10 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.